Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, Randomized Study to Assess the Metabolics, Efficacy, and Safety of Once-daily Darunavir Versus Atazanavir in HIV-infected Treatment-naive Adult Patients

NCT00757783 is registered in ClinicalTrials.gov with Tibotec, Inc as lead sponsor.

NCT NCT00757783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00757783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, Randomized Study to Assess the Metabolics, Efficacy, and Safety of Once-daily Darunavir Versus Atazanavir in HIV-infected Treatment-naive Adult Patients
Lead sponsor
Tibotec, Inc
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2008
Completion date
July 31, 2012
Enrollment
68 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hiv